Evidence map›Paper›PMID 42801676›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Probing the Energy Landscape of α-Synuclein Amyloid Fibril Formation by Systematic K-to-Q Mutagenesis.

Antonin Kunka, Azad Farzadfard, Jacob Aunstrup Larsen, Rasmus Krogh Norrild, Federica Saraceno, Celia Fricke, Hossein Mohammad-Beigi, Ahmed Sadek, Jonas Folke, Susana Aznar and 1 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Antonin KunkaDepartment of Biotechnology and Biomedicine, Technical University of Denmark, Lyngby, Denmark.ORCID https://orcid.org/0000-0002-1170-165X
Azad FarzadfardDepartment of Biotechnology and Biomedicine, Technical University of Denmark, Lyngby, Denmark.
Jacob Aunstrup LarsenDepartment of Biotechnology and Biomedicine, Technical University of Denmark, Lyngby, Denmark.ORCID https://orcid.org/0000-0002-6782-0594
Rasmus Krogh NorrildDepartment of Biotechnology and Biomedicine, Technical University of Denmark, Lyngby, Denmark.ORCID https://orcid.org/0000-0002-9120-2745
Federica SaracenoDepartment of Biotechnology and Biomedicine, Technical University of Denmark, Lyngby, Denmark.ORCID https://orcid.org/0009-0008-8842-6319
Celia FrickeDepartment of Biotechnology and Biomedicine, Technical University of Denmark, Lyngby, Denmark.ORCID https://orcid.org/0009-0004-2039-6732
Hossein Mohammad-BeigiDepartment of Biotechnology and Biomedicine, Technical University of Denmark, Lyngby, Denmark.ORCID https://orcid.org/0000-0003-2303-795X
Ahmed SadekLaboratory of Protein Design and Immunoengineering, Institute of Bioengineering, School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.ORCID https://orcid.org/0009-0009-0724-7990
Jonas FolkeCentre For Neuroscience and Stereology, Department of Neurology, Copenhagen University Hospital, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.ORCID https://orcid.org/0000-0002-0940-3098
Susana AznarCentre For Neuroscience and Stereology, Department of Neurology, Copenhagen University Hospital, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.ORCID https://orcid.org/0000-0001-7940-6246
Alexander K BuellDepartment of Biotechnology and Biomedicine, Technical University of Denmark, Lyngby, Denmark.ORCID https://orcid.org/0000-0003-1161-3622

Funding

Danmarks Frie Forskningsfond DFF4285-00247BHorizon MSCA individual postdoctoral fellowship 101106115Lundbeck foundation R366-2021-169Lundbeck foundation R480-2024-1262Michael J. Fox Foundation MJFF-021293Michael J. Fox Foundation MJFF-026617Novo Nordisk Foundation NNF17SA0028392Novo Nordisk Foundation NNF21OC0065495This research was supported by the European Union 101088163Toyota Foundation
6 · The paper itself

Abstract

Aggregation of α-synuclein (αSyn) is a hallmark of Parkinson's disease, yet its pathological roles remain poorly understood. Elucidating these roles requires detailed knowledge of the free energy landscape of αSyn self-assembly, i.e. the states that can be populated and their mechanisms and rates of interconversion. Here, we quantitatively probe this landscape using systematic mutational analysis, focusing on electrostatic contributions. We designed and produced 41 αSyn variants containing one to six acetyllysine-mimicking (K-Q) mutations to dissect the effects on key assembly pathways, fibril stability, and polymorphism. We derived a quantitative framework for the analysis of mutational effects and used it to isolate general electrostatic from residue-specific effects on de novo αSyn aggregation. We established fibril stability and relative growth rate analysis as indirect biophysical probes of fibril polymorphism and identified K43Q+K45Q and K80Q as mutations with the most significant effect onamyloid formation. Moreover, we demonstrate that a subset of variants, most noticeably K58Q+K60Q, show differential sensitivity toward disease-derived fibril polymorphs in seed amplification assays. Clustering analysis reveals that the mutational effects map onto the structural context of the lysine residues in known αSyn fibril structures. Together, this work provides a scalable, quantitative framework for probing the complex αSyn assembly landscape using mutational analysis.

Indexed as

Energy LandscapeIDPsMutagenesisParkinson's DiseasePolymorph

Identifiers

PMID42801676
PMCPMC13616359

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.